Silverarc Capital Management, LLC Olema Pharmaceuticals, Inc. Transaction History
Silverarc Capital Management, LLC
- $298 Million
- Q1 2024
A detailed history of Silverarc Capital Management, LLC transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Silverarc Capital Management, LLC holds 515,317 shares of OLMA stock, worth $5.58 Million. This represents 1.96% of its overall portfolio holdings.
Number of Shares
515,317
Previous 573,830
10.2%
Holding current value
$5.58 Million
Previous $8.05 Million
27.54%
% of portfolio
1.96%
Previous 2.54%
Shares
4 transactions
Others Institutions Holding OLMA
# of Institutions
129Shares Held
56MCall Options Held
55KPut Options Held
41.3K-
Bvf Inc San Francisco, CA9.14MShares$98.9 Million3.1% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY7.9MShares$85.5 Million3.36% of portfolio
-
Logos Global Management LP San Francisco, CA4.38MShares$47.4 Million4.62% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.23MShares$34.9 Million1.21% of portfolio
-
Black Rock Inc. New York, NY3.22MShares$34.8 Million0.0% of portfolio
About Olema Pharmaceuticals, Inc.
- Ticker OLMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,419,600
- Market Cap $437M
- Description
- Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...